A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)
Clinical trial NCT06964165 · TERMINATED
Trial details
- NCT number
- NCT06964165
- Sponsor
- Tesaro, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2024-06-28
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.